About US
Contact us
-
PPPI-III conference to focus on fundamental research and industrial application of particulate processingOver 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coa2011/1/14
-
Veeva Systems Introduces iRep Pharma App for iPadVeeva Systems has introduced the pharmaceutical industry's first complete customer relationship management and closed loop marketing application for the Apple iPad. iRep includes a sophisticated c2011/1/14
-
GlaxoSmithKline Slashes Price of NHS Parkinson's DrugGlaxoSmithKline has announced that it will reduce the price of ReQuip XL (ropinirole prolonged release) by 60% as part of a commitment to deliver cheaper medicines to the NHS. The NHS has rejected2011/1/13
-
Bayer Begins Enrolment for GIST Drug TrialBayer HealthCare has initiated patient enrolment for an international Phase III trial evaluating investigational regorafenib (BAY 73-4506) as a treatment for metastatic or unresectable gastrointestina2011/1/13
-
FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myelomaSenesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT), announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's lead dr2011/1/4
-
SinoFresh, Green Valley Drug enter marketing relationship for Homeopathic Antiseptic Nasal SpraySinoFresh® HealthCare, Inc., (Pink Sheets:SFSH) is pleased to announce that its marketing division has secured an agency marketing relationship with Green Valley Drug, http://www.greenvalleymed.co2011/1/4
-
Akorn-Strides joint venture enters purchase agreement with Pfizer for ANDAsAkorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviate2010/12/31
-
Cardiome Provides Update for Oral Vernakalant Development ProgramVANCOUVER, Dec. 29 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has been advised by its partner, Merck (known as MSD outside the United States and Canada), th2010/12/30
-
ISP to increase prices on 1,4 Butanediol (BDO) and derivatives sold in North America, including N-Methyl-2-Pyrrolidone (NMP), Gamma-Butyrolactone (BLO) and Tetrahydrofuran (THF).Wayne, NJ - December 8, 2010 – International Specialty Products Inc. (“ISP”) has announced a 5% price increase for 1,4 Butanediol (BDO) and derivatives sold in North America, including N-Methyl-2-Pyrr2010/12/30
-
ActivBiotics Pharma, LLC Terminates its Association with Triobiotics Pharma AGAtlanta– December 28, 2010 – ActivBiotics Pharma, LLC announced today that it has mutually agreed with former Triton Pharma AG to terminate their previously announced acquisition of ActivBiotics Pharm2010/12/29